Unlocking the Potential of PAQR5: A Drug Target and Biomarker

Target Name: PAQR5

NCBI ID: G54852

PAQR5

Unlocking the Potential of PAQR5: A Drug Target and Biomarker

Phosphatidylserine (PS) is a well-known phospholipid that is involved in various cellular processes. It is a major component of the cell membrane and plays a crucial role in maintaining the structural and functional integrity of the cell. The phosphatidylserine gene (PAQR5) has been identified as a potential drug target and biomarker. This article will discuss the scientific literature on PAQR5, its potential as a drug target, and its potential as a biomarker for various diseases.

Potential Drug Target

PAQR5 is a gene that encodes a protein known as PS-4. The protein encoded by PAQR5 is composed of 110 amino acids and has a calculated molecular mass of 11.4 kDa. It is located in the cytoplasm and is involved in various cellular processes, including the regulation of adhesion, migration, and invasion.

PAQR5 has been shown to be involved in the regulation of cell adhesion and migration. It has been shown to play a role in the formation of tight junctions, which are a type of cell-cell adhesion that is critical for maintaining tissue structure and function. In addition, PAQR5 has been shown to be involved in the regulation of cell migration, which is critical for the development and progression of various diseases, including cancer.

PAQR5 has also been shown to be involved in the regulation of cell invasion and metastasis. Its involvement in these processes has led to its potential as a drug target for various diseases, including cancer.

Potential Biomarker

PAQR5 has also been shown to be potential biomarker for various diseases. Its involvement in the regulation of cell adhesion, migration, and invasion makes it an attractive candidate for use as a biomarker for these diseases.

In cancer, PAQR5 has been shown to be involved in the regulation of cell adhesion, migration, and invasion, which makes it a potential biomarker for cancer. Studies have shown that higher levels of PAQR5 expression are associated with poor prognosis in various types of cancer, including breast, lung, and colorectal cancers.

In addition, PAQR5 has also been shown to be involved in the regulation of cell migration, which is a critical factor in the development and progression of cancer. Studies have shown that higher levels of PAQR5 expression are associated with the migration of cancer cells.

Conclusion

In conclusion, PAQR5 is a gene that encodes a protein involved in various cellular processes. Its potential as a drug target and biomarker makes it an attractive candidate for further research. Further studies are needed to fully understand its role in cellular processes and its potential as a drug target and biomarker for various diseases.

Protein Name: Progestin And AdipoQ Receptor Family Member 5

Functions: Plasma membrane progesterone (P4) receptor coupled to G proteins (PubMed:23763432). Seems to act through a G(i) mediated pathway (PubMed:23763432). May be involved in oocyte maturation (PubMed:12601167)

The "PAQR5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PAQR5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets